Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 3/20 | 0.65 |
| ▸ | DPP9 | Q86TI2 | 3/20 | 0.65 |
| ▸ | DPP8 | Q6V1X1 | 2/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | GRM8 | O00222 | 1/20 | 0.55 |
| ▸ | GRM6 | O15303 | 1/20 | 0.55 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.55 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.55 |
| ▸ | GSR | P00390 | 1/20 | 0.55 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.55 |
| ▸ | GRM5 | P41594 | 1/20 | 0.55 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.55 |
| ▸ | GRIA2 | P42262 | 1/20 | 0.55 |
| ▸ | GRIA3 | P42263 | 1/20 | 0.55 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.55 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.55 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.55 |
| ▸ | GRIA4 | P48058 | 1/20 | 0.55 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.55 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27996817 | 1.00 | DPP4 (0.65) | DPP4DPP9DPP8CYP1A2GRM8 | |
| SCHEMBL751143 | 1.00 | DPP4 (0.65) | DPP4DPP9DPP8CYP1A2GRM8 | |
| SCHEMBL29415456 | 1.00 | DPP4 (0.65) | DPP4DPP9DPP8CYP1A2GRM8 | |
| SCHEMBL2807373 | 0.96 | DPP4 (0.61) | DPP4DPP9DPP8CYP1A2GRM8 | |
| SCHEMBL29569099 | 0.96 | DPP4 (0.61) | DPP4DPP9DPP8CYP1A2GRM8 | |
| SCHEMBL31031060 | 0.96 | DPP4 (0.61) | DPP4DPP9DPP8CYP1A2GRM8 | |
| SCHEMBL30463268 | 0.92 | DPP4 (0.56) | DPP4DPP9DPP8CYP1A2GRM8 | |
| SCHEMBL29517333 | 0.92 | DPP4 (0.56) | DPP4DPP9DPP8CYP1A2GRM8 | |
| SCHEMBL29375127 | 0.91 | BACE1 (0.60) | DPP4DPP9DPP8CYP1A2GRM8 | |
| SCHEMBL29367962 | 0.91 | DPP4 (0.55) | DPP4DPP9DPP8CYP1A2GRM8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 305 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118897023-B | Method for directly measuring alpha and gamma-glutamyl peptide in skeletal muscle by using LC-MS and isotope dilution assay | 中国农业科学院北京畜牧兽医研究所 | 2025-03-25 | — | — | CN | claimed |
| US-20250059235-A1 | CYCLIC PEPTIDE ANTIVIRAL AGENTS AND METHODS USING SAME | UNIV DREXEL (US) | 2025-02-20 | — | — | US | claimed |
| CN-119104584-A | Diagnostic model and application thereof in diagnosis of aortic aneurysm | 首都医科大学附属北京友谊医院 | 2024-12-10 | — | — | CN | claimed |
| CN-118897023-A | Method for directly measuring alpha and gamma-glutamyl peptide in skeletal muscle by using LC-MS and isotope dilution assay | 中国农业科学院北京畜牧兽医研究所 | 2024-11-05 | — | — | CN | claimed |
| CN-118290518-A | Composition containing gamma-aminobutyric acid and active peptide and application of composition in preparation of product with muscle contraction inhibiting activity | 深圳海创生物科技有限公司 | 2024-07-05 | — | — | CN | claimed |
| CN-117756882-A | Preparation method of L-glutamyl-L-alanine | 武汉桀升生物科技有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-117304257-A | Active peptide, composition and application thereof in preparation of products with antioxidant and/or anti-aging effects | 深圳海创生物科技有限公司 | 2023-12-29 | — | — | CN | claimed |
| US-20230355708-A1 | COMPOSITIONS FOR INHIBITING VIRAL ENTRY AND METHODS USING SAME | UNIV DREXEL (US) | 2023-11-09 | — | — | US | claimed |
| CN-116836223-A | Prinsepia utilis royle active peptide composition and new application thereof | 昆明理工大学 | 2023-10-03 | — | — | CN | claimed |
| CN-112852905-B | Application of dipeptide in improving paramylon content in euglena | 优格天成生物技术(义乌)有限公司 | 2023-06-23 | — | — | CN | claimed |
| EP-3310191-A1 | SYNERGISTIC BEVERAGE COMPOSITION | Chigurupati, Harsha (IN) | 2018-04-25 | — | — | EP | claimed |
| CN-107920577-A | Synergistic beverage composition | 哈沙·奇古鲁帕蒂 | 2018-04-17 | — | — | CN | claimed |
| WO-2017216813-A1 | COMPOSITION TO REDUCE DNA AND HEPATIC DAMAGE AND TO ENHANCE REPAIR THEREOF | CHIGURUPATI HARSHA (IN) | 2017-12-21 | — | — | WO | claimed |
| US-20170362394-A1 | Composition to Reduce DNA and Hepatic Damage and to Enhance Repair Thereof | CHIGURUPATI, Harsha (IN) | 2017-12-21 | — | — | US | claimed |
| EP-3257513-A1 | COMPOSITION TO REDUCE DNA AND HEPATIC DAMAGE AND TO ENHANCE REPAIR THEREOF | Chigurupati, Harsha (IN) | 2017-12-20 | — | — | EP | claimed |
| WO-2016203499-A1 | SYNERGISTIC BEVERAGE COMPOSITION | CHIGURUPATI HARSHA (IN) | 2016-12-22 | — | — | WO | claimed |
| US-20160367478-A1 | Synergistic Beverage Composition | CHIGURUPATI, Harsha (IN) | 2016-12-22 | — | — | US | claimed |
| WO-2016196743-A1 | METHODS AND SYSTEMS FOR DETECTING MELANOMA | THE UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) | 2016-12-08 | — | — | WO | claimed |
| EP-2640423-A1 | LIPOYL COMPOUNDS AND THEIR USE FOR TREATING ISCHEMIC INJURY | Ischemix LLC (US) | 2013-09-25 | — | — | EP | claimed |
| WO-2012067947-A1 | LIPOYL COMPOUNDS AND THEIR USE FOR TREATING ISCHEMIC INJURY | ISCHEMIX LLC (US) | 2012-05-24 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250059235-A1 | CYCLIC PEPTIDE ANTIVIRAL AGENTS AND METHODS USING SAME | ZC3HAV1, VIP, LNPEP | DPP4 44/4885DPP9 62/4885DPP8 75/4885 |
| US-20230355708-A1 | COMPOSITIONS FOR INHIBITING VIRAL ENTRY AND METHODS USING SAME | GALNT1, GALNT2, LGALS1 | DPP4 1264/4885DPP9 1525/4885DPP8 1184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.